SRB Corp’s Bristol-Myers Squibb BMY Stock Holding History

SRB Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,585	Closed	-$440K	–	94
2023 Q3	$440K	Buy	7,585 +948	+14%	+$58.1K	0.03%	81
2023 Q2	$424K	Buy	6,637 +1,557	+31%	+$104K	0.02%	88
2023 Q1	$352K	Sell	5,080 -734	-13%	-$51.8K	0.02%	73
2022 Q4	$418K	Hold	5,814	–	–	0.03%	88
2022 Q3	$414K	Buy	+5,814	New	+$422K	0.03%	24
2020 Q1	–	Sell	-13,811	Closed	-$887K	–	173
2019 Q4	$887K	Buy	13,811 +4,253	+44%	+$244K	0.07%	11
2019 Q3	$484K	Sell	9,558 -777	-8%	-$36.5K	0.04%	67
2019 Q2	$469K	Buy	+10,335	New	+$481K	0.04%	148
2018 Q1	–	Sell	-3,111	Closed	-$191K	–	171
2017 Q4	$191K	Hold	3,111	–	–	0.02%	151
2017 Q3	$198K	Sell	3,111 -230	-7%	-$13.4K	0.03%	30
2017 Q2	$186K	Hold	3,341	–	–	0.03%	102
2017 Q1	$182K	Buy	+3,341	New	+$183K	0.03%	60

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SRB Corp's BMY Position: Q4 2023 in Review

SRB Corp sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 7,585 shares — an estimated $440K sold.

SRB Corp first reported a position in BMY in Q1 2017 and held it in 12 quarters. The position peaked at $887K in Q4 2019. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

SRB Corp reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
SRB Corp sold 7,585 Bristol-Myers Squibb shares in Q4 2023, an estimated $440K.
SRB Corp first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 12 quarters.
SRB Corp's Bristol-Myers Squibb position peaked at $887K in Q4 2019.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on SRB Corp's 13F filing for Q4 2023, filed 14 Feb 2024.